UP!

AMRI $21.74

AMRI target price
21.74
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-05-08 Reiterated Rating Morgan Stanley Buy
2015-10-26 Upgrade First Analysis Equal Weight to Overweight $25.00
2015-02-13 Set Price Target Morgan Stanley Buy $19.00
2014-12-18 Initiated Coverage First Analysis Equal Weight
2014-11-06 Reiterated Rating JPMorgan Chase & Co. Overweight $25.00 to $22.00
2014-09-09 Initiated Coverage JPMorgan Chase & Co. Overweight $25.00
2014-07-07 Reiterated Rating Morgan Stanley Underperform $13.00 to $15.00
2014-07-07 Reiterated Rating Sterne Agee CRT Underperform $13.00 to $15.00
2014-06-11 Reiterated Rating Morgan Stanley Overweight $19.00 to $21.00
2014-04-09 Initiated Coverage Morgan Stanley Overweight $19.00
2014-03-21 Downgrade Sterne Agee CRT Neutral to Underperform
2013-12-03 Downgrade Sterne Agee CRT Buy to Neutral $15.00 to $12.00
2008-07-17 Downgrade Jefferies & Co Buy to Hold $15.50
2007-06-20 Initiated Susquehanna Financial Neutral
2007-05-07 Upgrade Jefferies & Co Hold to Buy $11.50 to $14.50
2016-05-08 Reiterated Rating Morgan Stanley Buy
2015-10-26 Upgrade First Analysis Equal Weight to Overweight $25.00
2015-02-13 Set Price Target Morgan Stanley Buy $19.00
2014-12-18 Initiated Coverage First Analysis Equal Weight
2014-11-06 Reiterated Rating JPMorgan Chase & Co. Overweight $25.00 to $22.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
CABLE STUART M 11.95%  (3880983) AMRI /
D AMBRA CONSTANCE M 7.28%  (2365818) AMRI /
Nolan Michael M VP, CFO and Treasurer 0.21%  (68318) AMRI /
Sargent Bruce J Sr VP, Drug Discovery 0.17%  (55386) AMRI /
ROTH ARTHUR J 0.16%  (52575) AMRI / GLCH /
RYAN UNA S 0.16%  (51845) AMRI /
Jordan Veronica GH 0.12%  (37741) AMRI / VRML /
Luther Michael A Senior VP, Discovery Services 0.10%  (32455) AMRI / TBIO /
LEUNG GABRIEL 0.10%  (31316) AMRI / DCTH / PTX /